News

Deal Announcements

Apse Adds Venture Capital Equity Funding

Monday, September 29, 2014 5:30:00 AM PDT | VentureDeal
   St. Louis, Missouri  --  Biotechnology company Apse has raised $1.3 million in venture capital equity investment, according to an SEC regulatory filing.

Apse is developing a portfolio of novel RNA-based nanomaterials, that promises to reduce the current cost of RNA production by 100 to 1000 fold.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Apse is still seeking $596,000 in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1